tiprankstipranks
Trending News
More News >
Advertisement

GB:CURE ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Sell
7Bullish
0Neutral
15Bearish
Oscillators
Buy
7Bullish
0Neutral
3Bearish
Moving Averages
Strong Sell
0Bullish
0Neutral
12Bearish
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Moving Averages Convergence Divergence (MACD) indicator is -0.47, suggesting VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD is a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 20-Day exponential moving average is 22.17, making it a Sell.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-Day exponential moving average is 22.45, making it a Sell.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Pivot Points

Feb 13, 2026, 07:56 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
21.00
20.97
21.01
20.97
21.01
20.98
21.02
Fibonacci
20.97
20.97
20.97
20.97
20.97
20.97
20.98

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Moving Averages

Feb 13, 2026, 07:56 AM
Period
Simple
Exponential
MA5
21.28Sell
21.26Sell
MA10
21.80Sell
21.70Sell
MA20
22.49Sell
22.17Sell
MA50
22.66Sell
22.45Sell
MA100
22.37Sell
22.17Sell
MA200
21.22Sell
21.13Sell
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 10-Day exponential moving average is 21.70, making it a Sell.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-Day exponential moving average is 22.17, making it a Sell.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-day simple moving average is 22.66, creating a Sell signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-day simple moving average is 22.37, creating a Sell signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 200-day simple moving average is 21.22, creating a Sell signal.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Technical Analysis

Feb 13, 2026, 07:56 AM
Name
Value
Action
RSI (14)
27.73
Buy
STOCH (9,6)
8.69
Buy
STOCHRSI (14)
5.96
Buy
MACD (12,26)
-0.47
Buy
ADX (14)
19.96
Buy
Williams %R
-107.92
Buy
CCI (14)
-132.45
Buy
ATR (14)
0.27
-
Ultimate Oscillator
18.11
Sell
ROC
-11.83
Sell
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Relative Strength Index (RSI) is 27.73, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Trend Strength Indicator (ADX) is 19.96, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Commodity Channel Index (CCI) is -132.45, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Price Rate of Change (ROC) is -11.83, creating a Sell signal.

FAQ

Is CURE a Buy, Hold, or Sell?
Based on CURE’s technical indicators, CURE is a Sell.
    What is CURE’s RSI (14)?
    CURE’s RSI (14) is 27.73, which suggests CURE is a Buy.
      What is CURE’s MACD?
      CURE’s MACD is -0.47, which suggests CURE is a Buy.
        What is CURE’s 5-day moving average?
        CURE’s 5-day moving average is 21.28, which suggests CURE is a Sell.
          What is CURE’s 20-day moving average?
          CURE 20-day moving average is 22.49, which suggests CURE is a Sell.
            What is CURE’s 50-day moving average?
            CURE’s 50-day moving average is 22.66, which suggests CURE is a Sell.
              What is CURE’s 200-day moving average?
              CURE’s 200-day moving average is 21.22, which suggests CURE is a Sell.
                What is CURE’s Williams % R (14)?
                CURE’s Williams % R (14) is -107.92, which suggests CURE is a Buy.
                  What is CURE’s CCI (14)?
                  CURE’s CCI (14) is -132.45, which suggests CURE is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement